GAMA
UTHR icon

Graticule Asia Macro Advisors’s United Therapeutics UTHR Stock Holding History

Graticule Asia Macro Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Buy
+63
New +$35.5K ﹤0.01% 158

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Graticule Asia Macro Advisors's UTHR Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in United Therapeutics (UTHR) in Q2 2026: 63 shares worth $34.1K. The stake represents ﹤0.01% of the portfolio and ranks #158 among its holdings.

875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Graticule Asia Macro Advisors held 63 shares of United Therapeutics worth $34.1K as of Q2 2026.
  • United Therapeutics was a new Graticule Asia Macro Advisors position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #158 holding.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.